Europe Diagnostic Labs Market Size, Share, By Lab Type, Testing Services, Diseases, Revenue Source, and Country - Trends, Analysis, and Forecast till 2035

• The market by 2035 is imminent to grow at USD 45.0 billion.
• In 2024, market was valued at USD 29.1 billion.
• The market is burgeoning at a CAGR of 2.9%.

Diagnostic laboratory is a facility equipped with reagents, apparatus for performing diagnostic test and for detecting human infection. The rise in healthcare industries, rapid test kits, and rising cases of chronic diseases, and increasing rates of allergic diseases are factors, which bequeath to market expansion. Also, partnerships between firms help to accomplish diagnostic labs market growth in Europe over the forecast period.

Key Takeaways:

• Germany dominates the market due to presence of large number of laboratories.
• For instance, according to the data published by Robert Koch Institute, Currently, there are 21 National Reference Centres (NRCs) and 39 Consultant Laboratories (CLs), each appointed for three years. These laboratories are considered national centers of excellence in the field of laboratory science for a particular pathogen or group of pathogens. Of these, 5 NRCs and 13 CLs are currently situated to the Robert Koch Institute (RKI) and the others are located at various universities, federal or state institutes, private laboratories, and research facilities in Germany.

Key Drivers of Target Market:

Consumers Shift toward Point-of-Care Testing is Shaping the Market Expansion

Point-of-Care testing (POCT) has become critical to patient-centric healthcare due to the rapid diagnostic results required for accurate and faster treatment decisions. POCT can significantly improve infectious disease management, particularly in developing countries, such as Europe.

• For instance, according to the data published by National Library of Medicine, over the past decades the availability and use of POCT have steadily increased in Europe. POCT has been shown to yield measurable improvements in patient care, workflow efficiency, and even provide significant financial benefits. 

Restraints:

Shortage of Skilled Labor can Slowdown Growth of Target Market

There is a shortage of skilled labor in the laboratory sector. There is a lack of training opportunities, while at the same time more and more people working in the sector are working part-time or retiring. The recruitment of laboratory physicians and medical-technical laboratory assistants is becoming increasingly challenging and is slowing down the growth of industry turnover.

Counterbalance Statements: The key is offering support and mentoring with a provisional timeline so that prospective candidates may acquire the necessary education and training to become board-certified medical laboratory professionals who can then contribute to the workforce.

Opportunities:

Technological Upgradation Surge the Market Growth Opportunities

The demand for advanced technological diagnostic kits is increasing rapidly with the rising prevalence of acute and chronic diseases. In addition, technological developments in diagnostic kits have resulted in fewer manual errors, thus becoming a prominent driver of the diagnostic labs market. Thus, many key players are expanding their advance laboratory testing for customers across the region.

• For instance, In September 2022, ifp-labs, a laboratory group providing analytical testing services for food, feed, water and pharmaceuticals created by global, technology-focused investment firm Battery Ventures, announced its launch. With its headquarters in Berlin, ifp-labs will expand the advanced laboratory testing and technical support for customers across Europe.

Lab type, testing services, diseases, revenue source, and country are components on which market is segmented.

Lab Type

The market is diverged into several categories based on the lab type, including single/independent laboratories, hospital-based labs, physician office labs, and others. Among these, the hospital-based labs segment is superior in the market due to high volume of patients.

• For instance, in August 2024, Quest Diagnostics, a leading provider of diagnostic information services, and University Hospitals, one of the nation's leading nonprofit health systems and academic medical centers, announced a definitive agreement for Quest to acquire select assets of University Hospitals' outreach laboratory services business.

Testing Services

Diagnostic lab services are available through various testing services, such as physiological function testing, general & clinical testing, esoteric testing, specialized testing, non-invasive testing, COVID-19 testing, and others. The COVID-19 testing overshadow the target market due to pandemic which causes rapid growth in infected cases.

• For instance, in August 2020, Oxford Nanopore and the U.K. government’s Department of Health and Social Care (DHSC) have agreed to roll out the company’s novel LamPORE test, a COVID-19 diagnostic. Under the agreement, an initial 450,000 LamPORE SARS-CoV-2 test was available for use by a number of the U.K. National Health Service (NHS) testing laboratories.

Diseases

Cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, odontology, and others are the types of diseases at which the market is distinguished. However, oncology segment carried the massive share of the market. This is due to the increasing cases of cancer diseases caused by unhealthy lifestyle. 

• For instance, in March 2024, the DEFINITIVE project, led by IDIBAPS, will be conducted across 44 hospitals in a total of 7 European and associated countries to demonstrate that use of genomic test HER2DX improves quality of life in patients with early-stage HER2+ breast cancer while also maintaining drug efficacy.

Revenue Source

On the basis of revenue source, the market is broken down into healthcare plan, out-of-pocket, public system, and others. Healthcare plan dominates the Europe diagnostic labs market share as it offers coverage for various types of ailments & surgeries.

• For instance, in May 2022, the European Commission make health data easier to access for patients, medics, regulators, and researchers in a bid to improve diagnostics, cut unnecessary costs from duplication of medical tests, and boost medicine research. The document outlined the EU executive’s plans for a European health data space.

Europe Diagnostic Labs Market Report Scope:

Segmentation:

By Lab Type:

• Single/Independent Laboratories
• Hospital-Based Labs
• Physician Office Labs
• Others

By Testing Services:

• Physiological Function Testing
• General & Clinical Testing
• Esoteric Testing
• Specialized Testing
• Non-Invasive Testing
• COVID-19 Testing
• Others

By Diseases:

• Cardiology
• Oncology
• Neurology
• Orthopedics
• Gastroenterology
• Gynecology
• Odontology
• Others

By Revenue Source:

• Healthcare Plan
• Out-of-Pocket
• Public System

By Region:

• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

SYNLAB INTERNATIONAL, UNILABS, NELSON LABORATORIES, LLC, Sonic Healthcare Limited, and others are companies operating in the target market, which contributes to market expansion by implementing planning, such as collaborations, expansion, integration of advanced technologies, acquisition scenarios, and others. 

List of Key Players in the Market:

• SYNLAB INTERNATIONAL
• UNILABS
• NELSON LABORATORIES, LLC
• Sonic Healthcare Limited
• QUEST DIAGNOSTICS INCORPORATED
• EUROFINS SCIENTIFIC
• ACM GLOBAL LABORATORIES
• AMEDES MEDICAL SERVICES GMBH
• SIEMENS HEALTHCARE PRIVATE LIMITED
• NeoGenomics Laboratories
• Labcorp Genetics Inc.

• In November 2024, Pangea Laboratory has partnered with Unilabs, a leading European provider of clinical laboratory testing and diagnostic imaging services. Under this agreement, the Bladder CARE Assay will be covered by insurance, enhancing access for patients. This strategic collaboration aims to streamline cancer diagnostics in Switzerland, with plans for a broader rollout of Bladder CARE across Europe. 
• In October 2024, Eurofins Scientific, a global scientific leader in bio analytical testing, with a rapidly developing presence in highly specialized and molecular clinical diagnostics testing and in-vitro diagnostic products, has reached an agreement with SYNLAB to acquire its clinical diagnostics operations.
• In August 2024, Unilabs, a leading international provider of diagnostic services, and C2N Diagnostics, LLC, a pioneer in advanced diagnostic solutions in the field of Alzheimer’s disease (AD) and related neurological disorders, announced a major milestone in brain health diagnostics and research across Europe and beyond.
• In December 2023, the European Commission has appointed RISE (Research Institutes of Sweden) as a reference laboratory for medical devices for in vitro diagnostics, IVDR. RISE is one of the two laboratories in Europe appointed to evaluate products for in vitro diagnostics to diagnose virus-borne upper respiratory tract infections.

More Related Reports

Diagnostic Labs Market
Enterprise Digital Labs Market
Cholesterol Testing Services Market
Non-Destructive Testing Equipment Market
Asia Pacific Diagnostic Labs Market